Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications
Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead.
Commercially available AI increases breast cancer detection by nearly 20%
Results from the world’s largest prospective artificial intelligence study revealed the system could significantly benefit breast cancer screening programs.
Surgery outperforms PCI in NSTEMI patients with multivessel CAD
CABG was associated with a 41% lower risk of long-term mortality than PCI in a new study of more than 57,000 patients. The full analysis was published in European Heart Journal.
Boston Scientific enters IVL arms race with acquisition worth up to $664M
Boston Scientific has agreed to acquire Bolt Medical, a California-based medical device company focused on developing new intravascular lithotripsy technologies. The news comes less than one year after Johnson & Johnson acquired IVL pioneers Shockwave Medical for $13 billion.
FDA sees value in no-implant heart failure device
The new atrial shunt from Alleviant Medical was designed to treat heart failure without leaving a permanent implant behind. The FDA granted the technology its breakthrough device designation and approved additional research.

Rivaroxaban fails to prevent VTE after hospital discharge

For patients hospitalized with an acute illness, prescribing rivaroxaban for 45 days after discharge doesn’t significantly reduce the risk of venous thromboembolism (VTE) or VTE-related death, according to research presented at the European Society of Cardiology Congress and published online in the New England Journal of Medicine.

August 27, 2018

1-year outcomes still support culprit-only PCI for cardiogenic shock

For patients with acute myocardial infarction (MI) complicated by cardiogenic shock, stenting only the culprit lesion showed a trend toward improved one-year survival when compared to multivessel PCI, according to the latest results of the CULPRIT-SHOCK trial presented at the European Society of Cardiology Congress in Munich.

August 27, 2018

40% of AFib patients have ‘silent’ brain damage that could explain predisposition to dementia

More than 40 percent of patients with atrial fibrillation (AFib) but no record of stroke or transient ischemic attack have previously unknown, “silent” brain damage, according to research presented this week at the European Society of Cardiology Congress (ESC) in Munich. The findings might explain why those with AFib also face an increased risk of cognitive dysfunction and dementia.

August 27, 2018

Excessive forehead wrinkles may be early sign of atherosclerosis

Numerous, deep forehead wrinkles could be a visual cue that a patient is more at risk for cardiovascular disease (CVD), according to research presented Aug. 26 at the European Society of Cardiology (ESC) Congress in Munich.

August 27, 2018

Distal protection reduces no-reflow phenomenon among select PCI patients

Intravascular ultrasound may help identify patients who will benefit most from distal protection during percutaneous coronary intervention (PCI), according to a new study published in JACC: Cardiovascular Interventions.

August 24, 2018

NDEP revises principles for managing diabetes, prediabetes

The National Diabetes Education Program (NDEP) published an update to its “Guiding Principles” for managing the care of patients with diabetes or prediabetes.

August 24, 2018

Review: Heart failure trials lack women, older patients

Although heart failure researchers have made strides in enrolling more racial and ethnic minorities in clinical trials, women and older patients remain underrepresented, according to a systematic review published in JAMA Cardiology.

August 24, 2018

Smoking rates have been falling across the board—except for children under 15

Smoking rates have been dropping steadily in Europe since the 1970s, but, according to new research published in PLOS ONE, 11- to 15-year-olds are using tobacco more frequently.

August 24, 2018

Clinical

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications

Commercially available AI increases breast cancer detection by nearly 20%

Surgery outperforms PCI in NSTEMI patients with multivessel CAD

Boston Scientific enters IVL arms race with acquisition worth up to $664M

FDA sees value in no-implant heart failure device